首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   932篇
  免费   165篇
  国内免费   17篇
耳鼻咽喉   12篇
儿科学   49篇
妇产科学   9篇
基础医学   39篇
口腔科学   10篇
临床医学   156篇
内科学   284篇
皮肤病学   30篇
神经病学   45篇
特种医学   77篇
外科学   184篇
综合类   49篇
现状与发展   20篇
预防医学   59篇
眼科学   25篇
药学   18篇
中国医学   2篇
肿瘤学   46篇
  2024年   6篇
  2023年   42篇
  2021年   17篇
  2020年   23篇
  2019年   10篇
  2018年   52篇
  2017年   47篇
  2016年   32篇
  2015年   43篇
  2014年   40篇
  2013年   62篇
  2012年   29篇
  2011年   34篇
  2010年   48篇
  2009年   67篇
  2008年   42篇
  2007年   29篇
  2006年   31篇
  2005年   21篇
  2004年   10篇
  2003年   16篇
  2002年   14篇
  2001年   17篇
  2000年   12篇
  1999年   19篇
  1998年   29篇
  1997年   32篇
  1996年   44篇
  1995年   29篇
  1994年   17篇
  1993年   21篇
  1992年   7篇
  1991年   8篇
  1990年   10篇
  1989年   13篇
  1988年   15篇
  1987年   14篇
  1986年   11篇
  1985年   12篇
  1984年   4篇
  1983年   6篇
  1982年   8篇
  1981年   4篇
  1980年   5篇
  1978年   12篇
  1977年   8篇
  1976年   7篇
  1975年   5篇
  1964年   5篇
  1963年   4篇
排序方式: 共有1114条查询结果,搜索用时 31 毫秒
111.
112.
113.
114.

Background

Worldwide approximately 200 million adults undergo major surgery annually, of whom 8 million are estimated to suffer a myocardial injury after noncardiac surgery (MINS). There is currently no trial data informing the management of MINS. Antithrombotic agents such as direct oral anticoagulants might prevent major vascular complications in patients with MINS.

Methods

The Management of Myocardial Injury After Noncardiac Surgery (MANAGE) trial is a large international blinded randomized controlled trial of dabigatran vs placebo in patients who suffered MINS. We used a partial factorial design to also determine the effect of omeprazole vs placebo in reducing upper gastrointestinal bleeding and complications. Both study drugs were initiated in eligible patients within 35 days of suffering MINS and continued for a maximum of 2 years. The primary outcome is a composite of major vascular complications for the dabigatran trial and a composite of upper gastrointestinal complications for the omeprazole trial. We present the rationale and design of the trial and baseline characteristics of enrolled patients.

Results

The trial randomized 1754 patients between January 2013 and July 2017. Patients' mean age was 69.9 years, 51.1% were male, 14.3% had a history of peripheral artery disease, 6.6% had a history of stroke or transient ischemic attack, 12.9% had a previous myocardial infarction, and 26.0% had diabetes. The diagnosis of MINS was on the basis of an isolated ischemic troponin elevation in 80.4% of participants.

Conclusion

MANAGE is the first randomized controlled trial to evaluate a potential treatment of patients who suffered MINS.  相似文献   
115.
Gastric function was assessed in Wistar rats which received propantheline bromide by daily injection for 20 weeks. The results were compared with those from two control groups, one of which was injected daily with saline for 20 weeks. Gastric acid secretion, as measured by test meal and after ligation of the pylorus, was similar in all three groups. Acid secretion, as measured by test meal with pentagastrin 100 µg/kg body weight, gastric emptying, and fundic mucosal volume, expressed in terms of body weight, were all significantly increased in rats given propantheline. Only those measurements of acid secretion obtained by test meal with pentagastrin showed a significant correlation with fundic mucosal volume. Hence, since this method provides the most accurate indication of secretory capacity, it is concluded that the prolonged parenteral administration of propantheline may lead to an increase in parietal cell mass and its correlate, maximal secretory capacity. The mechanism by which these changes are produced is obscure.The author is grateful to Mr. Howard Ireson for his expert technical assistance, and to Mr. Ralph Marshall, Department of Medical Illustration, Cardiff Royal Infirmary, for the photography employed.Propantheline bromide (Pro-Banthine) was generously supplied by G. D. Searle and Co., Ltd.  相似文献   
116.
Osteomyelitis (bone infection) and neuro-osteoarthropathy (Charcot arthropathy) are limb-threatening complications of diabetic neuropathy with very different therapies. Distinguishing between them may be difficult, but it is important. In Charcot arthropathy, noninfectious soft tissue inflammation accompanies rapidly progressive destruction, first of joints, then of bone. This occurs in a well-vascularized and severely neuropathic, but nonulcerated, foot. In osteomyelitis, chronic soft tissue ulceration precedes infection of bone, which may be physically exposed. Magnetic resonance imaging and bone biopsy are the preferred diagnostic tests, provided adequate technical and interpretive skills are available.  相似文献   
117.
H+ secretion was studied in guinea pig fundic mucosa incubated in (A) bicarbonate-Ringer's gassed with 95% O2-5% CO2, or (B) HEPES gassed with 100% O2 before and after luminal pH was lowered to 2.0 for periods up to 90 min. At pH 2.0 for 60 min, H+ secretion in group A tissues fell by 35±4% (P=0.02) from a control rate of 1.35±0.09 eq/cm2/hr and in group B tissues by 50±11% (P=0.01) from a control rate of 1.59±0.08 eq/cm2/hr. After 90 min at pH 2.0, H+ secretion in group A fell by 53±8% (P=0.02) from a control rate of 1.47±0.07 eq/cm2/hr and in group B fell by 44±6% (P=0.01) from a control rate of 1.38±0.07 eq/cm2/hr. Histamine 1×10–4 M stimulation following exposure to pH 2.0 for 90 min increased secretion in group A tissues from 0.80 ±0.14 to 1.06±0.13 eq/cm2/hr (P<0.05), compared with an increase in nonacidified controls from 1.15±0.22 to 1.80±0.20 eq/cm2/hr (P<0.05) and in group B tissues from 1.27±0.10 to 1.56±0.19 eq/cm2/hr (P<0.05) compared with nonacidified controls from 1.43±0.22 to 2.23±0.41 eq/cm2/hr (P<0.05). Secretory function and electrical characteristics were adversely affected by luminal acidification to pH 2.0 and suggested a breach in the mucosal barrier with damage to parietal cells.This study was funded by the National Institute of Health Grant No. AM 15681.  相似文献   
118.
119.
120.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号